US$ 22.44
glp 1 agonist new In the ATTAIN-1 phase 3, randomized trial, the use of orforglipron Beyond GLP-1: New 5-In-1 Compound
Description
The most obvious symptoms of PD in the early stages are tremor, limb stiffness, decreased motor function and abnormal gait

However, at present primary care staff cannot prescribe GLP-1 RA for obesity and currently must refer patients to specialist weight management services

Physiol Rev

As in the case of GLP-1RA, the significance of this finding which is reversible with discontinuation of therapy is unclear
Limited RCTs have been published thus far on patient populations with hypertension specifically, with blood pressure variations being measured as a primary endpoint and tracked long-term

GLP-1 medications have been getting a lot of attention in recent yearsand for good reason
